O

Olive View UCLA Medical Center | Neurology Department

Research site

(Unclaimed)

Location

14445 Olive View Drive, Sylmar, California, United States of America

Site insights

Top conditions

Top treatments

Tiotropium

Remibrutinib

Platinum

Paclitaxel

Isavuconazonium sulfate

NXL104

VB-111

Testosterone

Salmeterol

Ivermectin

Parent organization

This site is a part of Olive View UCLA Medical Center

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)

The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in pa...

Active, not recruiting

Hidradenitis Suppurativa

Drug: Placebo 1

Drug: Placebo 2

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of remibrutinib (LOU064) in adult participants with moderate...

Enrolling

Hidradenitis Suppurativa

Drug: Remibrutinib

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN (APPARENT)

This study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of ip...

Enrolling

IC-MPGN

Drug: iptacopan

Drug: Placebo